Evidence map›Paper›PMID 31484802›Full record

ArticleTobacco control2020

Altria-Juul Labs deal: why did it occur and what does it mean for the US nicotine delivery product market.

David T Levy, David Sweanor, Luz Maria Sanchez-Romero, Richard O'Connor, Maciej Lukasz Goniewicz, Ron Borland

Abstract read
In one paragraph

Article in Tobacco control, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Do Tobacco Companies Have an Incentive to Promote "Harm Reduction" Products?: The Role of Competition.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

David T LevyOncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA dl777@georgetown.edu.ORCID 0000-0001-5280-3612
David SweanorFaculty of Law and Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Luz Maria Sanchez-RomeroOncology, Georgetown University, Washington, District of Columbia, USA.
Richard O'ConnorDepartment of Health Behavior, Roswell Park Cancer Institute, Buffalo, New York, USA.
Maciej Lukasz GoniewiczCancer Prevention and Population Sciences, Roswell Park Cancer Institute, Buffalo, New York, USA.
Ron BorlandSchool of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0003-0059-178X

Funding

Research Project 3: Modeling the Impact of Tobacco Control Policies on Polytobacco Use and Associated Health DisparitiesU54CA229974 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David Mendez Emilien · 2018 to 2026
$39.2M
Vaporized Nicotine Product Initiation Among Youth in the US, Canada, and England: Methods to Predict Uptake and Policy EfficacyP01CA200512 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FONG, GEOFFREY T · 2016 to 2025
$25.3M
NCI NIH HHS P01 CA200512NCI NIH HHS U54 CA229974
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Electronic Nicotine Delivery SystemsVapingHumansNicotineNicotineelectronic nicotine delivery devicesharm reductiontobacco industry

Identifiers

PMID31484802
PMCPMC7279136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.